Skip to main content
Log in

Deficiency of AMP deaminase in erythrocytes

  • Original Investigations
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

Six individuals with complete deficiency of erythrocyte AMP deaminase have been discovered. They are all healthy and have no hematological disorders. The deficiency is only in isozyme E, which is the erythrocyte type isozyme, and is inherited as an autosomal recessive trait. The frequency of the mutant gene is surprisingly high, one heterozygote in about 30 of the population in Japan, Seoul, and Taipei. The ATP level is approximately 50% higher in AMP-deficient erythrocytes compared to that of control cells. Degradation of adenine nucleotide is slower in the deficient erythrocytes than in the control erythrocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Askari A, Rao SN (1968) Regulation of AMP deaminase by 2,3-diphosphoglyceric acid: a possible mechanism for the control of adenine nucleotide metabolism in human erythrocytes. Biochim Biophys Acta 151:198–203

    Google Scholar 

  • Bergmeyer HU, Gawehn K, Grassl M (1974) Enzymes as biochemical reagents. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York London, pp 425–522

    Google Scholar 

  • Bougusky RT, Lowenstein LM, Lowenstein JM (1976) The purine nucleotide cycle. A pathway for ammonia production in the kidney. J Clin Invest 58:326–335

    Google Scholar 

  • Chapman AG, Atkinson DE (1973) Stabilization of adenylate energy charge by the adenylate deaminase reaction. J Biol Chem 248: 8309–8312

    Google Scholar 

  • Coffee CJ, Solano C (1977) Rat muscle 5′-adenylic acid aminohydrolase — role of K+ and adenylate energy charge in expression of kinetic and regulatory properties. J Biol Chem 252:1606–1612

    Google Scholar 

  • Cunningham B, Lowenstein JM (1965) Regulation of adenylate deaminase by adenosine triphosphate. Biochim Biophys Acta 96: 535–537

    Google Scholar 

  • Fishbein WN, Arumbrustmacher VW, Griffin JL (1978) Myoadenylate deaminase deficiency — a new muscle disease. Science 200:545–548

    Google Scholar 

  • Hershfield MS, Snyder FF, Seegmiller JE (1977) Adenine and adenosine are toxic to human lymphoblast mutant defective in purine salvage enzyme. Science 197:1284–1287

    Google Scholar 

  • Lamprecht W, Trautschold I (1974) Adenosine-5′-triphosphate determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York London, pp 2101–2110

    Google Scholar 

  • Lowenstein JM, Tornheim K (1971) Ammonia production in muscle: the purine nucleotide cycle. Science 171:397–400

    Google Scholar 

  • Michal G (1974) d-Glycerate-2,3-diphosphate. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York London, pp 1433–1438

    Google Scholar 

  • Moss KM, McGivan JD (1975) Characteristics of aspartate deamination by the purine nucleotide cycle in the cytosol fraction of rat liver. Biochem J 150:275–283

    Google Scholar 

  • Ogasawara N, Goto H, Yamada Y, Watanabe T (1978) Distribution of AMP-deaminase isozyme in rat tissues. Eur J Biochem 87:297–304

    Google Scholar 

  • Ogasawara N, Goto H, Yamada Y, Watanabe T, Asano T (1982) AMP deaminase isozymes in human tissues. Biochim Biophys Acta 714:298–306

    Google Scholar 

  • Ogasawara N, Goto H, Yamada Y, Nishigaki I, Itoh T, Hasegawa I (1984a) Complete deficiency of AMP deaminase in human erythrocytes. Biochem Biophys Res Commun 122:1344

    Google Scholar 

  • Ogasawara N, Goto H, Yamada Y, Watanabe T (1984b) Distribution of AMP deaminase isozymes in various human blood cells. Int J Biochem 16:269–273

    Google Scholar 

  • Randerath K, Randerath E (1967) Thin-layer separation methods for nucleic acid derivatives. Methods Enzymol 12:323–347

    Google Scholar 

  • Sabina RL, Swain JL, Patten BM, Ashizawa T, O'Brien WE, Holmes EW (1980) Disruption of the purine nucleotide cycle: a potential explanation for muscle dysfunction in myoadenylate deaminase deficiency. J Clin Invest 66:1419–1423

    Google Scholar 

  • Sabina RL, Swain JL, Olanow CW, Bradley WG, Fishbein WN, DiMauro S, Holmes EW (1984) Myoadenylate deaminase deficiency: functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest 73:720–730

    Google Scholar 

  • Schultz V, Lowenstein JM (1976) Purine nucleotide cycle: evidence for the occurrence of the cycle in brain. J Biol Chem 251:485–492

    Google Scholar 

  • Setlow B, Lowenstein JM (1967) Adenylate deaminase. II. Purification and some regulatory properties of the enzyme from calf brain. J Biol Chem 242:607–615

    Google Scholar 

  • Setlow B, Burger R, Lowenstein JM (1966) Adenylate deaminase. I. The effects of adenosine and guanosine triphosphates on activity and the organ distribution of the regulated enzyme. J Biol Chem 241:1244–1245

    Google Scholar 

  • Tornheim K, Lowenstein JM (1975) The purine nucleotide cycle: control of phosphofructokinase and glycolytic oscillations in muscle extracts. J Biol Chem 250:6304–6314

    Google Scholar 

  • Yamada Y, Goto H, Ogasawara N (1981) Adenosine kinase from human liver. Biochim Biophys Acta 660:36–43

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogasawara, N., Goto, H., Yamada, Y. et al. Deficiency of AMP deaminase in erythrocytes. Hum Genet 75, 15–18 (1987). https://doi.org/10.1007/BF00273831

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00273831

Keywords

Navigation